Evidence map›Paper›PMID 31316058›Full record

ArticleNature communications2019

Involvement of cigarette smoke-induced epithelial cell ferroptosis in COPD pathogenesis.

Masahiro Yoshida, Shunsuke Minagawa, Jun Araya, Taro Sakamoto, Hiromichi Hara, Kazuya Tsubouchi, Yusuke Hosaka, Akihiro Ichikawa, Nayuta Saito, Tsukasa Kadota and 17 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 311 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
311citing papers in PubMed, 1 pooled it
35.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

311 citing papers in PubMed, 1 synthesis or guideline pooled it, 544 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. AARS1-Mediated RUNX3 K193 Lactylation Enhances the Activation and Cytotoxicity of CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  8. Review
  9. Hyperoxia and iron homeostasis in developing human airway smooth muscle.American journal of physiology. Lung cellular and molecular physiology · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Iron and the lung: emerging roles of iron metabolism in pulmonary disease pathogenesis and therapy.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. AgJournal of nanobiotechnology · 2026
    Article

251 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 2 institutions in 1 country.

Masahiro YoshidaDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, 105-8461, Tokyo, Japan.ORCID http://orcid.org/0000-0002-3521-5322
Shunsuke MinagawaDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, 105-8461, Tokyo, Japan. shunske@jikei.ac.jp.ORCID http://orcid.org/0000-0003-1732-4856
Jun ArayaDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Taro SakamotoLaboratory of Hygienic Chemistry and Medicinal Research Laboratories, School of Pharmaceutical Sciences, Kitasato University, 108-8641, Tokyo, Japan.
Hiromichi HaraDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Kazuya TsubouchiDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Yusuke HosakaDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Akihiro IchikawaDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Nayuta SaitoDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Tsukasa KadotaDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, 105-8461, Tokyo, Japan.ORCID http://orcid.org/0000-0002-9533-7241
Nahoko SatoDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Yusuke KuritaDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Kenji KobayashiDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Saburo ItoDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Hirohumi UtsumiDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Hiroshi WakuiDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Takanori NumataDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Yumi KanekoDivision of Chest Diseases, Department of Surgery, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Shohei MoriDivision of Chest Diseases, Department of Surgery, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Hisatoshi AsanoDivision of Chest Diseases, Department of Surgery, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Makoto YamashitaDivision of Chest Diseases, Department of Surgery, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Makoto OdakaDivision of Chest Diseases, Department of Surgery, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Toshiaki MorikawaDivision of Chest Diseases, Department of Surgery, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Katsutoshi NakayamaDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Takeo IwamotoDivision of Molecular Cell Biology, Core Research Facilities for Basic Science, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Hirotaka ImaiLaboratory of Hygienic Chemistry and Medicinal Research Laboratories, School of Pharmaceutical Sciences, Kitasato University, 108-8641, Tokyo, Japan.
Kazuyoshi KuwanoDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, 105-8461, Tokyo, Japan.
Jikei University School of Medicine · JPKitasato University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ferroptosis is a necrotic form of regulated cell death (RCD) mediated by phospholipid peroxidation in association with free iron-mediated Fenton reactions. Disrupted iron homeostasis resulting in excessive oxidative stress has been implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD). Here, we demonstrate the involvement of ferroptosis in COPD pathogenesis. Our in vivo and in vitro models show labile iron accumulation and enhanced lipid peroxidation with concomitant non-apoptotic cell death during cigarette smoke (CS) exposure, which are negatively regulated by GPx4 activity. Treatment with deferoxamine and ferrostatin-1, in addition to GPx4 knockdown, illuminate the role of ferroptosis in CS-treated lung epithelial cells. NCOA4-mediated ferritin selective autophagy (ferritinophagy) is initiated during ferritin degradation in response to CS treatment. CS exposure models, using both GPx4-deficient and overexpressing mice, clarify the pivotal role of GPx4-regulated cell death during COPD. These findings support a role for cigarette smoke-induced ferroptosis in the pathogenesis of COPD.

Indexed as

FerroptosisSmokingAnimalsEpithelial CellsHumansIronLipid PeroxidationMice, Inbred C57BLMice, TransgenicNuclear Receptor CoactivatorsPhospholipidsPulmonary Disease, Chronic ObstructiveReactive Oxygen SpeciesIronNCOA4 protein, humanNuclear Receptor CoactivatorsPhospholipidsReactive Oxygen Species

Identifiers

PMID31316058
PMCPMC6637122
OpenAlexW2961268319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.